DavidLMurrayMD

PubMed

• 343 citations
  Proliferative Activity and Invasiveness among Pituitary Adenomas and Carcinomas: An Analysis Using the MIB-1 Antibody
  Kamal Thapar, K. Kovacs, Bernd W. Scheithauer, Lucia Stefaneanu, Eva Horvath
  Neurosurgery. 1996-01-01
• 100 citations
  Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases.
  Maria Alice V. Willrich, David L. Murray, Melissa R. Snyder
  Translational Research. 2015-02-01
• 13 citations
  Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases.
  Surendra Dasari, Mindy C Kohlhagen, Angela Dispenzieri, Maria A V Willrich, Melissa R Snyder
  Mayo Clinic Proceedings. 2022-02-01

Journal Articles

• A Universal Solution for Eliminating False Positives in Myeloma Due to Therapeutic Monoclonal Antibody Interference  
  David L Murray, Angela Dispenzieri, Blood

Abstracts/Posters

• Prognostic Implications of Serum Monoclonal Protein Positivity By Mass-Fix in Bone Marrow Minimal Residual Disease Negative (MRD-) Patients with Multiple Myeloma
  David L Murray, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis
  David L Murray, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease
  David L Murray, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Current Status of Clinical Laboratory Testing of Plasma Cell Neoplasms: A Case-Based Approach 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019